Sogol (Goli) Mostoufi-Moab, MD, MSCE is an Associate Professor of Pediatrics at the University of Pennsylvania School of Medicine, with co-appointments in the divisions of Oncology and Endocrinology at the Children’s Hospital of Philadelphia (CHOP). She received her bachelor’s degrees in French and Biology from the University of Missouri-Columbia and her MD (suma cum laude) from the Pennsylvania State University. Dr. Mostoufi-Moab completed her residency in pediatrics followed by a dual, combined fellowship in Pediatric Endocrinology and Hematology/Oncology at CHOP, along with a Master of Science in Clinical Epidemiology at the University of Pennsylvania.
Dr. Mostoufi-Moab’s clinical research program investigates the epidemiology and mechanism of endocrine late effects. The objective of her research is to discover and translate new knowledge into novel treatments for endocrine outcomes, particularly for children, adolescents, and young adult survivors of childhood cancer. Her research has been supported by grants from the NIH/NCI with a focus on the long-term negative impact of intense, multi-modal cancer therapy (chemotherapy and radiation) on the musculoskeletal system and body composition in childhood cancer survivors.
Clinically, Dr. Mostoufi-Moab is a member of the solid tumor group at CHOP and treats patients with endocrine tumors as well as endocrine late effects after cancer therapy. She is the Founding Director for the Program in Pediatric Survivorship and Outcomes Research, Director of the Endocrine Late Effects after Cancer Therapy program and the Associate Director of the Thyroid Center at CHOP. She is an active member of the Children’s Oncology Group, Childhood Cancer Survivor Study (Chronic Disease Working Group), American Society of Clinical Oncology, American Society of Pediatric Hematology Oncology, and Endocrine Society. She is a frequent invited lecturer on Endocrine Late Effects and an active participant in national and international harmonization groups for guideline development in Survivorship. Her career mission is to train the next generation of providers in the field of Survivorship and late effects of cancer therapy.
Learning Objectives:
- Describe long-term impact of cancer therapy on the endocrine system
- Illustrate lessons learned from retinoids and growth plate disruption
- Interpret prognostic significance of sarcopenia and frailty
Speaker:
This seminar was delivered as a Pediatric Grand Rounds Lecture at Children’s Hospital of Philadelphia, on December 4, 2024.
Content Disclaimer
The Terms of Use and Privacy Policy set forth on the website of The Children’s Hospital of Philadelphia apply to any and all uses of and access to this site and the content found here.
The work presented in the presentations, videos, and other content on this site (“Presentations”) includes publicly available medical evidence, a consensus of medical practitioners, and/or opinions of individual practitioners that may differ from consensus opinions. These Presentations are intended only to provide general information and need to be adapted for each specific patient based on the practitioner’s professional judgment, consideration of any unique circumstances, the needs of each patient and their family, the availability of various resources at the health care institution where the patient is located, and other factors. The Presentations are not intended to constitute medical advice or treatment, nor should they be relied upon as such. The Presentations are not intended to create a doctor-patient relationship between/among The Children’s Hospital of Philadelphia, its physicians and the individual patients in question. The information contained in these Presentations are general in nature, and do not and are not intended to refer to specific patients.
CHOP, The Children’s Hospital of Philadelphia Foundation and its or their affiliates, the authors, presenters, practitioners, editors, and others associated with the creation of the Presentations (“CHOP”) are not responsible for errors or omissions in the Presentations; for any outcomes a patient might experience where a clinician reviewed one or more such Presentations in connection with providing care for that patient; and/or for any and all third party content on the site or in the Presentations. CHOP makes no warranty, expressed or implied, with respect to the currency, completeness, applicability or accuracy of the Presentations. Application of the information in or to a particular situation remains the professional responsibility of the practitioner who is directly treating the patient.
To the extent that the Presentations include information regarding drug dosing, in view of ongoing research, changes in government regulations and the constant flow of information relating to drug therapy and drug reactions, the viewer should not rely on the Presentation content, but rather is urged to check the package insert for each drug for indications, dosage, warnings and precautions.
Some drugs and medical devices presented in the Presentations have United States Food and Drug Administration (FDA) clearance for limited use in restricted research settings. It is the responsibility of the practitioner to ascertain the FDA status of each drug or device planned for use in their clinical practice.
You shall indemnify, defend and hold harmless CHOP, The Children’s Hospital of Philadelphia Foundation, and its/their current and former employees, officers, and agents, trustees, and their respective successors, heirs and assigns (“Indemnitees”) against any claims, liability, damage, loss or expenses (including attorneys’ fees and expenses of litigation) in connection with any claims, suits, actions, demands or judgments arising directly or indirectly out of your reference to or use of the Presentations.
The Presentations are protected by copyright laws and in some cases patent laws, and all rights are reserved under such laws. No part of the Presentations may be reproduced in any form by any means, or utilized in any other way, absent prior written permission from the copyright owner.
By starting this module, you agree to our Content Disclaimer and Terms of Service.
Course Includes
- 1 Lesson
- Course Certificate